Takeda Pharmaceutical Company Limited (TAK)

NYSE • Currently up 0.11 (+0.60%) in today's trading session

1 member of Congress has disclosed 1 trade in Takeda Pharmaceutical Company Limited (TAK) via STOCK Act filings. The most recent disclosure was a sale by Virginia Foxx on 29 August 2023. Aggregate disclosed activity totals roughly $32.5K in sales (midpoint estimates from bracketed disclosure amounts).

Takeda Pharmaceutical Company Limited is currently trading at $18.35, positioned at 91% of its 52-week range ($12.99 – $18.90).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$18.35
24h Change
+0.11 (+0.60%)
52 Week Range
$12.99—$18.90
View on NASDAQ

Takeda Pharmaceutical Company Limited Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TAK

Select to highlight on chart
1 transactions
Compliance: 100%
Virginia Foxx29 Aug 20235 Sept 2023SaleStock$15,001 - $50,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$58.39B

Volume

1.25M

Beta

0.09

P/E Ratio

13.19

Fundamentals

EPS

$1.39

Div. Yield

3.44%

Open

$18.21

Day Range

$18.21 — $18.36

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE · USD
Country
JP
CEO
Julie So-Young Kim
IPO Date
2010-01-05
Website
www.takeda.com

Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vas...

Earnings

Next Report

Q3 2026

29 Oct

EPS Est.

$0.14

Rev. Est.

$7.3B

Days Until

64

Recent Quarters

Q2 202630 Jul
EPS$0.23
Beat 33.2%
Q1 202613 May
EPS$-0.05
Miss 123.4%
Q4 202529 Jan
EPS$0.21
Miss 61.3%
Q3 202530 Oct
EPS$-0.02
Miss 105.7%
Q2 202530 Jul
EPS$0.52
Beat 10.6%
Q1 20258 May
EPS$-0.22
Miss 193.5%
Q4 202430 Jan
EPS$0.05
Miss 85.6%
Q3 202431 Oct
EPS$0.19
Miss 51.0%
Q2 202431 Jul
EPS$0.20
Miss 45.1%
Q1 20249 May
EPS$-0.01
Miss 345.1%
Q4 20231 Feb
EPS$0.23
Beat 133.9%
Q3 202326 Oct
EPS$-0.10
Miss 207.1%
Q2 202327 Jul
EPS$0.20
Beat 44.5%
Q1 202311 May
EPS$0.08
Beat 49.7%
Q4 20222 Feb
EPS$0.46
Beat 62.1%
Q3 202227 Oct
EPS$0.52
Beat 289.2%
Q2 202228 Jul
EPS$0.56
Beat 135.8%
Q1 202211 May
EPS$0.38
Beat 527.1%
Q4 20213 Feb
EPS$0.54
Beat 144.9%
Q3 202128 Oct
EPS$0.45
Beat 92.9%
Q2 202130 Jul
EPS$0.51
Beat 54.6%
Q1 202111 May
EPS$0.41
Beat 42.1%
Q4 20204 Feb
EPS$0.56
Beat 4.5%
Q3 202029 Oct
EPS$0.47
Miss 99.5%
Q2 202031 Jul
EPS$0.57
Miss 99.5%
Q1 202013 May
EPS$0.13
Beat 159.7%
Q4 20194 Feb
EPS$0.53
Miss 99.3%
Q3 201931 Oct
EPS$0.59
Beat 374.8%
Q2 201931 Jul
EPS$0.56
Beat 392.4%
Q1 201914 May
EPS$0.13
Beat 136.4%
Q4 20181 Feb
EPS$0.75
Beat 310.2%
Q3 201831 Oct
EPS$0.27
Q2 201831 Jul
EPS$0.45
Q1 201814 May
EPS$-0.16
Q3 201731 Dec
EPS$0.38
Q2 201730 Sept
EPS$0.16
Q1 201730 Jun
EPS$0.82
Q4 201631 Mar
EPS$-0.29
Q3 201631 Dec
EPS$0.23
Q2 201630 Sept
EPS$0.16
Q1 201630 Jun
EPS$0.31
Q4 201531 Mar
EPS$-0.10
Q3 201531 Dec
EPS$0.16
Q2 201530 Sept
EPS$0.08
Q1 201530 Jun
EPS$0.06
Q4 201431 Mar
EPS$-0.60
Q3 201431 Dec
EPS$0.05
Q2 201430 Sept
EPS$0.08
Q1 201430 Jun
EPS$0.10
Q4 201331 Mar
EPS$-0.01
Q3 201331 Dec
EPS$0.19
Q2 201330 Sept
EPS$0.14
Q1 201330 Jun
EPS$0.09
Q4 201231 Mar
EPS$-0.03
Q3 201231 Dec
EPS$0.08
Q2 201230 Sept
EPS$0.13
Q1 201230 Jun
EPS$0.35
Q4 201131 Mar
EPS$-0.14
Q3 201131 Dec
EPS$0.10
Q2 201130 Sept
EPS$0.25
Q1 201130 Jun
EPS$0.30
Q4 201031 Mar
EPS$0.12
Q3 201031 Dec
EPS$0.28
Q2 201030 Sept
EPS$0.30
Q1 201030 Jun
EPS$0.23
Q4 200931 Mar
EPS$0.13
Q3 200931 Dec
EPS$0.24
Q2 200930 Sept
EPS$0.27
Q1 200930 Jun
EPS$0.37
Q4 200831 Mar
EPS$0.21
Q3 200831 Dec
EPS$0.30
Q2 200830 Sept
EPS$0.21

Dividends

Dividend History

31 Mar 2026
Amount $0.3083
30 Sept 2025
Amount $0.3221
31 Mar 2025
Amount $0.2760
30 Sept 2024
Amount $0.3261
27 Mar 2024
Amount $0.2922
28 Sept 2023
Amount $0.3191
30 Mar 2023
Amount $0.3100
29 Sept 2022
Amount $0.3296
30 Mar 2022
Amount $0.3301
29 Sept 2021
Amount $0.3969
30 Mar 2021
Amount $0.4066
29 Sept 2020
Amount $0.4305
30 Mar 2020
Amount $0.4190
27 Sept 2019
Amount $0.4111
27 Mar 2019
Amount $0.3552
26 Sept 2018
Amount $0.3955
27 Mar 2018
Amount $0.4064
27 Sept 2017
Amount $0.3995
29 Mar 2017
Amount $0.3989
29 Sept 2016
Amount $0.3924
30 Mar 2016
Amount $0.4370
29 Sept 2015
Amount $0.3653
30 Mar 2015
Amount $0.3653
28 Sept 2014
Amount $0.3783
27 Mar 2014
Amount $0.4437
26 Sept 2013
Amount $0.4370
27 Mar 2013
Amount $0.4571
26 Sept 2012
Amount $0.5460
28 Mar 2012
Amount $0.5638
28 Sept 2011
Amount $0.5786
29 Mar 2011
Amount $0.5558
28 Sept 2010
Amount $0.5332
25 Sept 2009
Amount $0.5178
26 Mar 2009
Amount $0.4818
25 Sept 2008
Amount $0.4681

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about TAK

Which members of Congress have traded TAK?
1 member of Congress has disclosed 1 trade in Takeda Pharmaceutical Company Limited (TAK) under the STOCK Act: Virginia Foxx.
When was TAK most recently disclosed by Congress?
The most recent TAK disclosure was a sale by Virginia Foxx on 29 August 2023.
What is the total disclosed congressional trading volume for TAK?
Members of Congress have disclosed approximately $32.5K in TAK sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in TAK?
This TAK page updates as soon as new STOCK Act disclosures are filed for Takeda Pharmaceutical Company Limited. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.